Development of a Sustained-Release Oral Tablet of Tyrosine Kinase Inhibitor Imatinib Using Full Factorial Design. (2024). Dhaka University Journal of Pharmaceutical Sciences, 23(2), 135-143. https://doi.org/10.3329/dujps.v23i2.78571